Dalbavancin Effective Treatment For Gram-Positive Infections In Patients Who Use Drugs, Study Finds

Infectious Disease Advisor (6/3, Chan) reports, “Dalbavancin is an effective treatment option for severe invasive gram-positive infections in people who use drugs, according to study results published in Open Forum Infectious Diseases.” In the study, “at 90 days, 73.1% of patients who reported drug use and 74.5% of those with no history of drug use achieved clinical cure (P =.08). In both groups, the researchers observed higher clinical cure rates in those who completed the intended course of dalbavancin (77.3% vs 50% and 75.0% vs 71.4%, respectively).”